228 related articles for article (PubMed ID: 38504551)
1. A review of the therapeutic potential of the cysteinyl leukotriene antagonist Montelukast in the treatment of bronchiolitis obliterans syndrome following lung and hematopoietic-stem cell transplantation and its possible mechanisms.
Kordjazy N; Amini S
Ther Adv Respir Dis; 2024; 18():17534666241232284. PubMed ID: 38504551
[TBL] [Abstract][Full Text] [Related]
2. Prospective Phase II Trial of Montelukast to Treat Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation and Investigation into Bronchiolitis Obliterans Syndrome Pathogenesis.
Williams KM; Pavletic SZ; Lee SJ; Martin PJ; Farthing DE; Hakim FT; Rose J; Manning-Geist BL; Gea-Banacloche JC; Comis LE; Cowen EW; Justus DG; Baird K; Cheng GS; Avila D; Steinberg SM; Mitchell SA; Gress RE
Transplant Cell Ther; 2022 May; 28(5):264.e1-264.e9. PubMed ID: 35114411
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic effect of budesonide/formoterol, montelukast and N-acetylcysteine for bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation.
Kim SW; Rhee CK; Kim YJ; Lee S; Kim HJ; Lee JW
Respir Res; 2016 May; 17(1):63. PubMed ID: 27229850
[TBL] [Abstract][Full Text] [Related]
4. Fluticasone, Azithromycin, and Montelukast Treatment for New-Onset Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation.
Williams KM; Cheng GS; Pusic I; Jagasia M; Burns L; Ho VT; Pidala J; Palmer J; Johnston L; Mayer S; Chien JW; Jacobsohn DA; Pavletic SZ; Martin PJ; Storer BE; Inamoto Y; Chai X; Flowers MED; Lee SJ
Biol Blood Marrow Transplant; 2016 Apr; 22(4):710-716. PubMed ID: 26475726
[TBL] [Abstract][Full Text] [Related]
5. Montelukast for bronchiolitis obliterans syndrome after lung transplantation: A randomized controlled trial.
Ruttens D; Verleden SE; Demeyer H; Van Raemdonck DE; Yserbyt J; Dupont LJ; Vanaudenaerde BM; Vos R; Verleden GM
PLoS One; 2018; 13(4):e0193564. PubMed ID: 29624575
[TBL] [Abstract][Full Text] [Related]
6. LTB4 and montelukast in transplantation-related bronchiolitis obliterans in rats.
Tu ZL; Zhou ZY; Xu HC; Cao JL; Ye P; Wang LM; Lv W; Hu J
J Cardiothorac Surg; 2017 May; 12(1):43. PubMed ID: 28545478
[TBL] [Abstract][Full Text] [Related]
7. Montelukast for bronchiolitis obliterans syndrome after lung transplantation: a pilot study.
Verleden GM; Verleden SE; Vos R; De Vleeschauwer SI; Dupont LJ; Van Raemdonck DE; Vanaudenaerde BM
Transpl Int; 2011 Jul; 24(7):651-6. PubMed ID: 21401732
[TBL] [Abstract][Full Text] [Related]
8. Relevance of Plasma Matrix Metalloproteinase-9 for Bronchiolitis Obliterans Syndrome after Allogeneic Hematopoietic Cell Transplantation.
Inamoto Y; Martin PJ; Onstad LE; Cheng GS; Williams KM; Pusic I; Ho VT; Arora M; Pidala J; Flowers MED; Gooley TA; Lawler RL; Hansen JA; Lee SJ
Transplant Cell Ther; 2021 Sep; 27(9):759.e1-759.e8. PubMed ID: 34126278
[TBL] [Abstract][Full Text] [Related]
9. Detection of Bronchiolitis Obliterans Syndrome Using Nitrogen Multiple Breath Washout in Children Posthemopoietic Stem Cell Transplant.
Westrupp N; Berry CD; Cole T; Shanthikumar S; Welsh L
Transplant Cell Ther; 2024 May; 30(5):524.e1-524.e9. PubMed ID: 38360272
[TBL] [Abstract][Full Text] [Related]
10. Time to explore preventive and novel therapies for bronchiolitis obliterans syndrome after allogeneic hematopoietic stem cell transplantation.
Sengsayadeth SM; Srivastava S; Jagasia M; Savani BN
Biol Blood Marrow Transplant; 2012 Oct; 18(10):1479-87. PubMed ID: 22449611
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of safety and efficacy of allogeneic adipose tissue-derived mesenchymal stem cells in pediatric bronchiolitis obliterans syndrome (BoS) after allogeneic hematopoietic stem cell transplantation (allo-HSCT).
Mohseni R; Mahdavi Sharif P; Behfar M; Modaresi MR; Shirzadi R; Mardani M; Jafari L; Jafari F; Nikfetrat Z; Hamidieh AA
Stem Cell Res Ther; 2023 Sep; 14(1):256. PubMed ID: 37726865
[TBL] [Abstract][Full Text] [Related]
12. Lung Function Trajectory in Bronchiolitis Obliterans Syndrome after Allogeneic Hematopoietic Cell Transplant.
Cheng GS; Storer B; Chien JW; Jagasia M; Hubbard JJ; Burns L; Ho VT; Pidala J; Palmer J; Johnston L; Mayer S; Crothers K; Pusic I; Lee SJ; Williams KM
Ann Am Thorac Soc; 2016 Nov; 13(11):1932-1939. PubMed ID: 27513368
[TBL] [Abstract][Full Text] [Related]
13. Proteomic Characterization Reveals That MMP-3 Correlates With Bronchiolitis Obliterans Syndrome Following Allogeneic Hematopoietic Cell and Lung Transplantation.
Liu X; Yue Z; Yu J; Daguindau E; Kushekhar K; Zhang Q; Ogata Y; Gafken PR; Inamoto Y; Gracon A; Wilkes DS; Hansen JA; Lee SJ; Chen JY; Paczesny S
Am J Transplant; 2016 Aug; 16(8):2342-51. PubMed ID: 26887344
[TBL] [Abstract][Full Text] [Related]
14. Interstitial lung diseases after hematopoietic stem cell transplantation: New pattern of lung chronic graft-versus-host disease?
Archer G; Berger I; Bondeelle L; de Margerie-Mellon C; Cassonnet S; de Latour RP; Michonneau D; Chevret S; Bergeron A
Bone Marrow Transplant; 2023 Jan; 58(1):87-93. PubMed ID: 36309588
[TBL] [Abstract][Full Text] [Related]
15. Predictive value of bronchiolitis obliterans syndrome stage 0p in chronic graft-versus-host disease of the lung.
Abedin S; Yanik GA; Braun T; Pawarode A; Magenau J; Goldstein SC; Levine JE; Kitko CL; Couriel DR
Biol Blood Marrow Transplant; 2015 Jun; 21(6):1127-31. PubMed ID: 25687798
[TBL] [Abstract][Full Text] [Related]
16. Bronchiolitis obliterans syndrome after allogeneic hematopoietic stem cell transplantation-an increasingly recognized manifestation of chronic graft-versus-host disease.
Chien JW; Duncan S; Williams KM; Pavletic SZ
Biol Blood Marrow Transplant; 2010 Jan; 16(1 Suppl):S106-14. PubMed ID: 19896545
[TBL] [Abstract][Full Text] [Related]
17. Effects of montelukast, a cysteinyl-leukotriene type 1 receptor antagonist, on the pathogenesis of bleomycin-induced pulmonary fibrosis in mice.
Shimbori C; Shiota N; Okunishi H
Eur J Pharmacol; 2011 Jan; 650(1):424-30. PubMed ID: 21034736
[TBL] [Abstract][Full Text] [Related]
18. A Nasal Inflammatory Cytokine Signature Is Associated with Early Graft-versus-Host Disease of the Lung after Allogeneic Hematopoietic Cell Transplantation: Proof of Concept.
Ostrin EJ; Rider NL; Alousi AM; Irajizad E; Li L; Peng Q; Kim ST; Bashoura L; Arain MH; Noor LZ; Patel N; Mehta R; Popat UR; Hosing C; Jenq RR; Rondon G; Hanash SM; Paczesny S; Shpall EJ; Champlin RE; Dickey BF; Sheshadri A
Immunohorizons; 2023 Jun; 7(6):421-430. PubMed ID: 37289498
[TBL] [Abstract][Full Text] [Related]
19. Haploidentical donor stem cell transplantation had a lower incidence of bronchiolitis obliterans syndrome compared with HLA-matched sibling donor transplantation in patients with hematologic malignancies: Benefit from ATG?
Weng G; Fan Z; Xue H; Huang F; Xu N; Jin H; Yu S; Ye Z; Fan J; Xuan L; Liu Q
Front Immunol; 2022; 13():1036403. PubMed ID: 36389692
[TBL] [Abstract][Full Text] [Related]
20. Lung hyperinflation quantitated by chest CT in children with bronchiolitis obliterans syndrome following allogeneic hematopoietic cell transplantation.
Moutafidis D; Gavra M; Golfinopoulos S; Oikonomopoulou C; Kitra V; Woods JC; Kaditis AG
Clin Imaging; 2021 Jul; 75():97-104. PubMed ID: 33515927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
